Clinical Trial Update: Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of cyclophosphamide, topotecan, and bevacizumab (CTB) in relapsed/refractory neuroblastoma and sarcoma; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Sarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Topotecan (topotecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma, Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2019-10-29